Propanc Biopharma Inc
NASDAQ:PPCB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Propanc Biopharma Inc
NASDAQ:PPCB
|
AU |
|
North Media A/S
CSE:NORTHM
|
DK |
|
Raytheon Technologies Corp
NYSE:RTX
|
US |
|
A
|
Alamar Foods Company CJSC
SAU:6014
|
SA |
|
Unizyx Holding Corp
TWSE:3704
|
TW |
|
D
|
Discovery Lithium Inc
CNSX:DCLI
|
CA |
|
I
|
Inghams Group Ltd
F:IH1
|
AU |
|
Biodesix Inc
NASDAQ:BDSX
|
US |
|
Avation PLC
LSE:AVAP
|
SG |
|
M
|
Marathon Gold Corp
F:MC8
|
CA |
|
Bank of Kaohsiung Co Ltd
TWSE:2836
|
TW |
|
Lotte Data Communication Co
KRX:286940
|
KR |
|
Strongpoint ASA
F:PGT
|
NO |
|
A
|
Arizona Sonoran Copper Company Inc
OTC:ASCUF
|
CA |
|
Sarimelati Kencana Tbk PT
IDX:PZZA
|
ID |
Bankruptcy Probability
Propanc Biopharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Propanc Biopharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Propanc Biopharma Inc
OTC:PPCB
|
7.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
456.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
236.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.3B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Propanc Biopharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Propanc Biopharma Inc has total debt of 520.3k USD. This includes both short-term (520.3k USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
